How Important is Onset of Action in Ulcerative Colitis Therapy? Steven MassonDavid NylanderJohn C. Mansfield Current Opinion 17 September 2012 Pages: 2069 - 2083
Treatment of Epidermal Necrolysis with High-Dose Intravenous Immunoglobulins (IVIg) Ousmane FayeJean-Claude Roujeau Leading Article 17 September 2012 Pages: 2085 - 2090
Modern Malaria Chemoprophylaxis G. Dennis ShanksMichael D. Edstein Review Article 17 September 2012 Pages: 2091 - 2110
Pharmacological Treatment of Ankylosing Spondylitis Pauline BoulosMaxime DougadosElke Hunsche Review Article 17 September 2012 Pages: 2111 - 2127
Lansoprazole Katherine F. CroomLesley J. Scott Adis Drug Profile 17 September 2012 Pages: 2129 - 2135
Lansoprazole in the Treatment of Gastrooesophageal Reflux Disease in Children and Adolescents Vasundhara Tolia Adis Drug Profile 17 September 2012 Pages: 2136 - 2136
Lansoprazole in the Treatment of Gastro-oesophageal Reflux Disease in Children and Adolescents Yvan VandenplasSilvia Salvatore Adis Drug Profile 17 September 2012 Pages: 2136 - 2137
Palifermin in Myelotoxic Therapy-Induced Oral Mucositis Mohamad MohtyDidier Blaise Adis Drug Profile 17 September 2012 Pages: 2147 - 2147
Palifermin in Myelotoxic Therapy-Induced Oral Mucositis Nicole M. A. BlijlevensShaun McCann Adis Drug Profile 17 September 2012 Pages: 2147 - 2147
Palifermin in Myelotoxic Therapy-Induced Oral Mucositis Douglas E. Peterson Adis Drug Profile 17 September 2012 Pages: 2147 - 2147
Palifermin in Myelotoxic Therapy-Induced Oral Mucositis Stephen T. Sonis Adis Drug Profile 17 September 2012 Pages: 2147 - 2149
Ertapenem Gillian M. KeatingCaroline M. Perry Adis Drug Evaluation 17 September 2012 Pages: 2151 - 2178
Infliximab M. Asif A. SiddiquiLesley J. Scott Adis Drug Evaluation 17 September 2012 Pages: 2179 - 2208
Nelfinavir Caroline M. PerryJames E. FramptonRisto S. Cvetković Adis Drug Evaluation 17 September 2012 Pages: 2209 - 2244